Greenwich LifeSciences Ownership | Who Owns Greenwich LifeSciences?


OverviewRevenueFinancialsChart

Greenwich LifeSciences Ownership Summary


Greenwich LifeSciences is owned by 7.94% institutional investors, 52.93% insiders, and 39.13% retail investors. Blackrock is the largest institutional shareholder, holding 2.40% of GLSI shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.17% of its assets in Greenwich LifeSciences shares.

GLSI Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockGreenwich LifeSciences7.94%52.93%39.13%
SectorHealthcare Stocks 47.06%8.01%44.93%
IndustryBiotech Stocks 44.97%7.82%47.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock308.91K2.40%$5.33M
Vanguard group268.17K2.09%$4.63M
Geode capital management127.69K0.99%$2.20M
Credit agricole s a87.00K0.68%$1.50M
State street68.40K0.53%$1.18M
Renaissance36.90K0.29%$636.89K
Northern trust24.32K0.19%$419.76K
Charles schwab investment management18.45K0.14%$318.52K
Bank of new york mellon15.29K0.12%$263.99K
Morgan stanley7.05K0.05%$121.73K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Credit agricole s a87.00K0.01%$1.50M
Founders capital management500.000.01%$8.63K
Renaissance36.90K0.00%$636.89K
Corebridge financial3.21K0.00%$55.47K
Washington trust advisors200.000.00%$3.45K
Strs ohio4.80K0.00%$82.85K
Ameritas investment partners585.000.00%$10.10K
Geode capital management127.69K0.00%$2.20M
New york state common retirement fund6.00K0.00%$104.00K
Blackrock308.91K0.00%$5.33M

Top Buyers

HolderShares% AssetsChange
Blackrock308.91K0.00%252.45K
Credit agricole s a87.00K0.01%87.00K
Geode capital management127.69K0.00%69.44K
State street68.40K0.00%55.40K
Vanguard group268.17K0.00%45.07K

Top Sellers

HolderShares% AssetsChange
Millennium management---63.81K
Goldman sachs group---41.51K
Susquehanna group, llp---35.87K
Jane street group---20.64K
Qube research---17.32K

New Positions

HolderShares% AssetsChangeValue
Credit agricole s a87.00K0.01%87.00K$1.50M
Charles schwab investment management18.45K0.00%18.45K$318.52K
Bank of new york mellon15.29K0.00%15.29K$263.99K
Rhumbline advisers6.80K0.00%6.80K$117.34K
New york state common retirement fund6.00K0.00%6.00K$104.00K

Sold Out

HolderChange
Old point trust & financial services n a-100.00
Macquarie group-110.00
Game plan financial advisors-200.00
Tower research capital llc (trc)-530.00
Newbridge financial services group-1.90K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20243313.79%1,020,90458.33%731.52%2556.25%3-25.00%
Mar 31, 20242911.54%644,80320.31%528.84%166.67%4-
Dec 31, 20232613.04%535,932-0.26%423.85%15150.00%4-50.00%
Sep 30, 202323-537,344-14.54%417.46%6-40.00%814.29%
Jun 30, 202323-14.81%628,750-24.02%411.80%10-28.57%7-12.50%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv153.46K1.17%-
iShares Russell 2000 ETF141.70K1.08%-322.00
PV BUYBACK USA Classe B USD87.00K0.66%-
Vanguard Institutional Extnd Mkt Idx Tr71.31K0.54%-
Fidelity Small Cap Index61.70K0.47%-1.12K
iShares Russell 2000 Growth ETF50.66K0.39%-
Fidelity Extended Market Index33.19K0.25%1.94K
State St Russell Sm Cap® Indx SL Cl I28.50K0.22%-
Vanguard Russell 2000 ETF27.21K0.21%-170.00
NT R2000 Index Fund - NL14.61K0.11%14.61K

Recent Insider Transactions


DateNameRoleActivityValue
Sep 26, 2024Patel Snehal CEO and CFOBuy$21.95K
Aug 12, 2024Thompson Jaye VP Clinical Reg AffairsBuy$11.08K
Aug 06, 2024Patel Snehal CEO and CFOBuy$27.62K
Aug 05, 2024Patel Snehal CEO and CFOBuy$72.49K
Aug 02, 2024Thompson Jaye VP Clinical Reg AffairsBuy$15.15K

Insider Transactions Trends


DateBuySell
2024 Q35-
2024 Q22-
2024 Q16-
2023 Q47-
2023 Q37-

GLSI Ownership FAQ


Who Owns Greenwich LifeSciences?

Greenwich LifeSciences shareholders are primarily institutional investors at 7.94%, followed by 52.93% insiders and 39.13% retail investors. The average institutional ownership in Greenwich LifeSciences's industry, Biotech Stocks , is 44.97%, which Greenwich LifeSciences falls below.

Who owns the most shares of Greenwich LifeSciences?

Greenwich LifeSciences’s largest shareholders are Blackrock (308.91K shares, 2.40%), Vanguard group (268.17K shares, 2.09%), and Geode capital management (127.69K shares, 0.99%). Together, they hold 5.48% of Greenwich LifeSciences’s total shares outstanding.

Does Blackrock own Greenwich LifeSciences?

Yes, BlackRock owns 2.40% of Greenwich LifeSciences, totaling 308.91K shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 5.33M$. In the last quarter, BlackRock increased its holdings by 252.45K shares, a 447.14% change.

Who is Greenwich LifeSciences’s biggest shareholder by percentage of total assets invested?

Credit agricole s a is Greenwich LifeSciences’s biggest shareholder by percentage of total assets invested, with 0.01% of its assets in 87K Greenwich LifeSciences shares, valued at 1.5M$.

Who is the top mutual fund holder of Greenwich LifeSciences shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Greenwich LifeSciences shares, with 1.17% of its total shares outstanding invested in 153.46K Greenwich LifeSciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools